6505--Acyclovir Capsules (VA-25-00048078)
ID: 36E79725R0033Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/ec732205ccd141c6a2608fd06ac0978f/view
Timeline
  1. 1
    Posted Mar 31, 2025, 12:00 AM UTC
  2. 2
    Updated Mar 31, 2025, 12:00 AM UTC
  3. 3
    Due May 1, 2025, 7:30 PM UTC
Description

The Department of Veterans Affairs is seeking proposals for the procurement of Acyclovir Capsules, specifically 200MG capsules in two packaging sizes, to support the healthcare needs of veterans. The solicitation includes two line items: Line Item 1 requires 3,256 bottles of 100 capsules per bottle, and Line Item 2 requests 15,475 bottles of 500 capsules per bottle, with the same quantities needed for the base year and each of the four option years. This procurement is crucial for ensuring a reliable supply of essential pharmaceuticals for veterans, emphasizing the importance of compliance and competition within the pharmaceutical supply chain. Interested suppliers must submit their pricing proposals by May 1, 2025, and can contact Contracting Officer Andrew Cazares at andrew.cazaeres@va.gov or (708) 786-4990 for further details.

Point(s) of Contact
Andrew CazaresContracting Officer
(708) 786-4990
andrew.cazaeres@va.gov
Files
Title
Posted
36E79725R0033_1.docx
Mar 31, 2025, 1:04 PM UTC
The Presolicitation Notice from the Department of Veterans Affairs (VA) outlines a request for proposals (RFP) for Acyclovir Capsules, specifically soliciting bids for two line items related to the drug's supply. The document provides essential information regarding the solicitation number (36E79725R0033), response deadline (May 1, 2025), and details the quantity and packaging specifications for the capsules. Line Item 1 requires 3,256 bottles of Acyclovir 200MG capsules (100 capsules per bottle) for the base year and each of the four option years. Line Item 2 requests 15,475 bottles of Acyclovir 200MG capsules (500 capsules per bottle) under the same terms. Offerors must submit pricing for both items to be considered, ensuring their bids do not exceed two decimal places. The main purpose of this presolicitation notice is to inform potential suppliers about the upcoming procurement for the VA, emphasizing the required quantities and the submission process. This is instrumental for federal contracting, facilitating competition and compliance within the pharmaceutical supply chain specifically for veterans' healthcare needs.
Lifecycle
Title
Type
6505--Acyclovir Capsules (VA-25-00048078)
Currently viewing
Presolicitation
Similar Opportunities
6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets
Buyer not available
The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300mg Tablets, which will serve various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract aims to ensure an uninterrupted supply of this essential medication for a period of one year, with options for four additional one-year terms, emphasizing the VA's commitment to maintaining critical pharmaceutical supplies. The estimated annual requirement is approximately 91,583 bottles, and interested offerors must ensure their product has a unique National Drug Code (NDC) and complies with specific packaging requirements, including safety caps. The solicitation is expected to be issued electronically on or around April 26, 2025, with a response deadline of May 13, 2025; inquiries can be directed to Deb Fassl at Deborah.Fassl@va.gov.
6505--Topiramate Tablets (VA-25-00047941)
Buyer not available
The Department of Veterans Affairs (VA) is seeking proposals for the supply of Topiramate Tablets, a pharmaceutical product essential for meeting the medication needs of VA facilities and other government agencies. The procurement aims to establish a contract through the VA Pharmaceutical Prime Vendor Program, requiring offerors to submit detailed proposals that include pricing for a base year and four option years, with a 0.5% Cost Recovery Fee incorporated. Compliance with the Drug Supply Chain Security Act (DSCSA), adherence to specific packaging requirements, and maintenance of current Good Manufacturing Practices (cGMP) verified by the FDA are critical components of the contract. Interested parties should contact Contract Specialist Billy Fong at Billy.Fong@va.gov for further details regarding the solicitation.
6505--Loperamide Capsules (VA-25-00032225)
Buyer not available
The Department of Veterans Affairs (VA) is seeking proposals for the supply of Loperamide Hydrochloride (HCL) 2mg capsules, as outlined in solicitation number 36E79725R0025. Offerors must provide pricing for a base year and four additional one-year options, including a 0.5% Cost Recovery Fee and unique 11-digit National Drug Codes (NDC) for their products, while adhering to regulatory standards such as the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This procurement is crucial for ensuring the availability of essential pharmaceutical products to VA facilities and other government health service providers. The deadline for proposal submissions has been extended to April 30, 2025, at 2:30 PM Central Time, and interested parties should contact Contract Specialist Nicholas I McGregor at Nicholas.McGregor@va.gov for further information.
6505--Ranolazine Sustained Action (SA) Tablets
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Ranolazine Sustained Action Tablets, a pharmaceutical product essential for veteran healthcare. Bidders are required to submit pricing for a base year and four option years, along with compliance documentation including National Drug Code (NDC) numbers and adherence to packaging specifications as mandated by the Drug Supply Chain Security Act. This procurement underscores the government's commitment to ensuring a reliable supply of quality medications while adhering to federal standards, including Good Manufacturing Practices (cGMP). Interested parties should contact Contract Specialist Deborah S. Fassl at Deborah.Fassl@va.gov for further details regarding submission requirements and deadlines.
6505--Buspirone RFP
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Buspirone HCL, a pharmaceutical product essential for the healthcare services provided to veterans. The procurement process requires vendors to submit pricing for multiple line items covering a base year and four option years, ensuring compliance with the Drug Supply Chain Security Act and FDA Good Manufacturing Practices. This contract aims to maintain a reliable supply chain for federal healthcare providers, including the VA, Department of Defense, and Indian Health Service, while securing volume-based pricing for the necessary pharmaceuticals. Interested vendors must submit their offers by May 8, 2025, at 2:30 PM CT, and can direct inquiries to Contract Specialist Amber Zavala at amber.zavala@va.gov.
6505--Carvedilol Tablets (VA-25-00048048)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the supply of Carvedilol Tablets under solicitation number 36E79725R0028, with an amendment extending the submission deadline to May 1, 2025, at 2:30 PM Central Daylight Time. Offerors are required to provide pricing for various types of Carvedilol Tablets, submit unique National Drug Code (NDC) numbers, and comply with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and FDA manufacturing standards. This procurement is crucial for ensuring a reliable supply of pharmaceuticals to enhance healthcare services for veterans and active duty military personnel. Interested contractors should direct their proposals to the specified VA email addresses and acknowledge receipt of the amendment to remain eligible for consideration.
6505--Metformin IR Tablets
Buyer not available
The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Metformin HCL IR Tablets as part of its pharmaceutical prime vendor programs, which also serve the Department of Defense (DoD). Offerors are required to submit pricing for various bottle sizes and quantities, ensure compliance with FDA regulations, and adhere to the Drug Supply Chain Security Act (DSCSA), including providing a unique National Drug Code (NDC) for each product. This procurement is crucial for maintaining a reliable source of pharmaceutical products, ensuring consistent availability and pricing while meeting federal regulatory standards. Interested parties should contact Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov for further details, and proposals must be submitted in accordance with the outlined requirements within the specified timeframe.
6505--Perphenazine Tablets (VA-25-00037353)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the procurement of Perphenazine tablets under solicitation number VA-25-00037353. This contract aims to ensure a reliable supply of this pharmaceutical product for both the Department of Veterans Affairs and the Department of Defense, with a focus on service-disabled veteran-owned, women-owned, and HUBZone small businesses. The procurement process will adhere to the Drug Supply Chain Security Act and require compliance with FDA regulations, including Good Manufacturing Practices. Interested offerors must submit their proposals by May 1, 2025, at 2:30 PM CDT, and can direct inquiries to Contract Specialist Anthony DiCrescenzo at Anthony.DiCrescenzo@va.gov.
NALTREXONE -50MG -100CT - Multiple CMOPs - 770-25-3-801-0426
Buyer not available
The Department of Veterans Affairs is preparing to solicit proposals for the procurement of 50mg Naltrexone tablets, packaged in 100-count bottles, for delivery to multiple Consolidated Mail Outpatient Pharmacies (CMOP) across the United States. This presolicitation notice (RFQ: 36C77025Q0114) indicates a commitment to full and open competition, allowing all responsible vendors to submit quotations by the response deadline of May 6, 2025, at 4 PM Central Time. The procurement of these pharmaceuticals is crucial for meeting the ongoing healthcare needs of veterans, ensuring compliance with regulatory standards such as the Drug Supply Chain Security Act. Interested vendors must direct their responses to Contract Specialist Jennifer Knight via email at jennifer.knight@va.gov, with the estimated issue date for the solicitation set for April 29, 2025.
770 - CLINDAMYCIN P04 1% TOP SWAB (770-25-3-801-0368)
Buyer not available
The Department of Veterans Affairs is soliciting proposals for the procurement of Clindamycin PO4 1% Top Swabs, specifically for use in its Consolidated Mail Outpatient Pharmacy (CMOP) facilities. Vendors are required to submit a detailed pricing schedule, confirm compliance with safety and labeling standards, and adhere to strict delivery protocols, including providing necessary documentation such as state licenses and bar code compliance. This procurement is crucial for ensuring the availability of quality pharmaceutical supplies for veterans, reflecting the VA's commitment to regulatory compliance and operational efficiency. Interested vendors must submit their proposals by April 30, 2025, and can contact Jennifer L. Knight at jennifer.knight@va.gov or 913-684-0162 for further information.